未登录 Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia 评估完全缓解/完全应答率作为慢性淋巴细胞白血病复发/难治状态下的替代终点。 Wang, Lin; Kurt, Murat; Disher, Tim; Liu, Fei Fei; Craigie, Samantha; Perna, Serena K.; Aronitz, Elise; Eyre, Toby A.; Ysebaert, Loic; Davids, Matthew S. 分享 收藏
分享 收藏
分享 收藏
Analysis of long-term efficacy outcomes from the CheckMate 025 (CM 025) trial comparing nivolumab (NIVO) vs everolimus (EVE) based on ≥ 7 years (yrs) of follow-up in pre-treated patients (pts) with advanced renal cell carcinoma (aRCC) Escudier, B.; Motzer, R. J.; Dyer, M.; May, J. R.; Ejzykowicz, F.; Kurt, M.; Lee, C-W.; Wang, P.; Testa, E.; Sharpe, D. J.; George, S.; Tannir, N. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Estimating long-term survivorship in patients with advanced melanoma treated with immune-checkpoint inhibitors: Analyses from the phase III CheckMate 067 trial Mohr, P.; Larkin, J.; Paly, V. F.; Azocar, A. Remiro; Baio, G.; Kurt, M.; Amadi, A.; Rizzo, J. I.; Johnson, H. M.; Moshyk, A.; Kotapati, S.; Middleton, M. 分享 收藏
分享 收藏
From Data to Improved Decisions: Operations Research in Healthcare Delivery Capan, Muge; Khojandi, Anahita; Denton, Brian T.; Williams, Kimberly D.; Ayer, Turgay; Chhatwal, Jagpreet; Kurt, Murat; Lobo, Jennifer Mason; Roberts, Mark S.; Zaric, Greg; Zhang, Shengfan; Schwartz, J. Sanford 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏